News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TNG Pharmaceuticals, Inc. Closes $4.6 Million Series A Financing


2/6/2014 10:39:41 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LOUISVILLE, Ky.--(BUSINESS WIRE)--TNG Pharmaceuticals, Inc. (TNG), an animal pharmaceutical company developing an innovative vaccine for cattle to aid in control of the horn fly, announced that it completed a $4.6 million Series A Preferred Stock financing on December 31, 2013.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES